Company intelligence / Profile preview

Frontage Clinical Services

Secaucus, New Jersey, United States

Ownership: Private
Development stage: Other

Overview

Frontage Clinical Services is an early-phase (Phase I–IIa) clinical trial operation providing full-service clinical pharmacology and biometrics support, including first-in-human, bioavailability/bioequivalence, interaction, cardiac safety, vaccine and proof-of-concept studies for a wide range of delivery routes, primarily as a service provider rather than a drug sponsor.[1][2][4][11]

Therapeutic areas: ImmunologyCardiovascularNeurologyDermatologyInfectious DiseasesPulmonologyGastroenterologyMetabolic Disorders
Modalities: Small moleculeBiologicVaccinePeptidesProtein
Industry: Contract Research Organization

Partnerships

Medicover Integrated Clinical Services (via genomic/clinical collaboration of Frontage Laboratories)[3]

Beyond the preview

Go deeper on Frontage Clinical Services.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Frontage Clinical Services.

Explore the full profile